AdvantaPure’s BioClosure container closures are intended to save time and money on inventoried parts, assembly, and cleaning validations.
The BioClosure container closures from AdvantaPure are standard, ready-to-use, closed systems. The closures feature elastomeric seals against the containers, and they allow unobstructed fluid paths. Applications include aseptic sampling, cell growth, filling, process R&D, and cold storage.
BioClosure System Assemblies include Single-Use AdvantaFlex fluid transfer tubing and molded container closures, plus filters and caps for media bottles, Erlenmeyer flasks, and carboys. The assemblies, offered in standardized configurations, are intended to save time and money on inventoried parts, assembly, and cleaning validations.
Other key features of the closed system assemblies include:
Container capacities range from 125 mL to two liters for media bottles, one and two liters for Erlenmeyer flasks, and 2.5 to 40 liters for carboys. Bottle and flask assemblies are provided gamma sterilized. Cap assemblies for carboys are available in two or three port styles and are offered non-sterile or gamma sterilized.
BioClosure System Assemblies are available in platinum-cured, Class VI silicone in addition to AdvantaFlex TPE. The company will showcase the systems at INTERPHEX 2016, in New York NY.
Source: AdvantaPure
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.